The role of ARHGEF7 and PTPRN2 in PCa is unknown, but ANO7 encodes a polytopic membrane protein that is prostate-specific [37], and the methylated CpG site in this gene might therefore be a promising biomarker for more aggressive PCa. The gene discussed is ANO7; the disease is posterior cortical atrophy.